| Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. R Dalla-Favera, M Bregni, J Erikson, D Patterson, RC Gallo, CM Croce Proceedings of the National Academy of Sciences 79 (24), 7824-7827, 1982 | 2320 | 1982 |
| Gene therapy for immunodeficiency due to adenosine deaminase deficiency A Aiuti, F Cattaneo, S Galimberti, U Benninghoff, B Cassani, L Callegaro, ... New England Journal of Medicine 360 (5), 447-458, 2009 | 1138 | 2009 |
| Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation AM Gianni, M Bregni, AC Stern, S Siena, C Tarella, A Pileri, G Bonadonna The Lancet 334 (8663), 580-585, 1989 | 960 | 1989 |
| Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients S Siena, M Bregni, B Brando, N Belli, F Ravagnani, L Gandola, AC Stern, ... | 690 | 1991 |
| Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte … S Siena, M Bregni, B Brando, F Ravagnani, G Bonadonna, AM Gianni | 685 | 1989 |
| High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma AM Gianni, M Bregni, S Siena, C Brambilla, M Di Nicola, F Lombardi, ... New England Journal of Medicine 336 (18), 1290-1298, 1997 | 645 | 1997 |
| Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase … F Ciceri, C Bonini, MTL Stanghellini, A Bondanza, C Traversari, ... The lancet oncology 10 (5), 489-500, 2009 | 546 | 2009 |
| Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009 P Ljungman, M Bregni, M Brune, J Cornelissen, T De Witte, G Dini, ... Bone marrow transplantation 45 (2), 219-234, 2010 | 500 | 2010 |
| Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic … P Corradini, A Dodero, F Zallio, D Caracciolo, M Casini, M Bregni, F Narni, ... Journal of Clinical Oncology 22 (11), 2172-2176, 2004 | 376 | 2004 |
| Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses EJ Villablanca, L Raccosta, D Zhou, R Fontana, D Maggioni, A Negro, ... Nature medicine 16 (1), 98-105, 2010 | 356 | 2010 |
| Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy. S Siena, M Di Nicola, M Bregni, R Mortarini, A Anichini, L Lombardi, ... Experimental hematology 23 (14), 1463-1471, 1995 | 297 | 1995 |
| The EBMT activity survey: 1990–2010 JR Passweg, H Baldomero, A Gratwohl, M Bregni, S Cesaro, P Dreger, ... Bone marrow transplantation 47 (7), 906-923, 2012 | 274 | 2012 |
| Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer M Bregni, A Dodero, J Peccatori, A Pescarollo, M Bernardi, I Sassi, ... Blood, The Journal of the American Society of Hematology 99 (11), 4234-4236, 2002 | 265 | 2002 |
| Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society … D Cardinale, F Ciceri, R Latini, MG Franzosi, MT Sandri, M Civelli, ... European journal of cancer 94, 126-137, 2018 | 229 | 2018 |
| Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in … AM Gianni, M Bregni, S Siena, A Orazi, AC Stern, L Gandola, ... Journal of Clinical Oncology 8 (5), 768-778, 1990 | 229 | 1990 |
| A proportion of patients with lymphoma may harbor mutations of the perforin gene R Clementi, F Locatelli, L Dupré, A Garaventa, L Emmi, M Bregni, ... Blood 105 (11), 4424-4428, 2005 | 221 | 2005 |
| Antitumor effects of HSV-TK–engineered donor lymphocytes after allogeneic stem-cell transplantation F Ciceri, C Bonini, S Marktel, E Zappone, P Servida, M Bernardi, ... Blood, The Journal of the American Society of Hematology 109 (11), 4698-4707, 2007 | 220 | 2007 |
| Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year … AM Gianni, S Siena, M Bregni, M Di Nicola, S Orefice, F Cusumano, ... Journal of clinical oncology 15 (6), 2312-2321, 1997 | 220 | 1997 |
| Safety of retroviral gene marking with a truncated NGF receptor C Bonini, M Grez, C Traversari, F Ciceri, S Marktel, G Ferrari, M Dinauer, ... Nature medicine 9 (4), 367-369, 2003 | 199 | 2003 |
| Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies P Corradini, C Tarella, A Olivieri, AM Gianni, C Voena, F Zallio, M Ladetto, ... Blood, The Journal of the American Society of Hematology 99 (1), 75-82, 2002 | 187 | 2002 |
